




Searching News Database: Tibotec Pharmaceuticals
HSMN NewsFeed - 20 Sep 2007
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
HSMN NewsFeed - 16 Feb 2007
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union
Additional items found! 2

Members Archive contains
2 additional stories matching:
Tibotec Pharmaceuticals
(Password required)
Tibotec Pharmaceuticals
(Password required)